The killer within: Endogenous bacteria accelerate oyster mortality during sustained anoxia

16 pages, 5 figures, 2 tablesSustained periods of anoxia, driven by eutrophication, threaten coastal marine systems and can lead to mass mortalities of even resilient animals such as bivalves. While mortality rates under anoxia are well-studied, the specific mechanism(s) of mortality are less clear. We used a suite of complementary techniques (LT50, histology, 16S rRNA amplicon sequencing, and valvometry) to show that the proliferation of anaerobic bacteria within eastern oysters (Crassostrea virginica) accelerates mortality rate under anoxic conditions. Manipulative laboratory experiments revealed that oyster survival under anoxic conditions was halved when bacteria were present compared to when they were excluded by the broad-spectrum antibiotic chloramphenicol. Histological assessments supported this mechanism and showed infiltration of bacteria in oysters that were not treated with antibiotics compared to a general lack of bacteria when oysters were treated with antibiotics. 16S rRNA amplicon sequencing failed to identify any particular genera of bacteria responsible for mortality, rather a diversity of endogenous anaerobic and/or sulfate-reducing bacteria were common among oysters. In addition, monitoring of oyster valve gaping behavior in the field revealed that oysters showed remarkable valve closure synchrony when first exposed to anoxia. However, oysters periodically opened throughout anoxia/hypoxia in both the lab and field, suggesting that the infiltration of exogenous bacteria from the environment may also influence mortality rates under natural settings. Coupled with previous studies, we posit that mass mortality events in a wide range of coastal bivalves are likely the result of co-morbidity from asphyxiation and bacterial processesThis study was funded by L'Étang Ruisseau Bar Ltd. in partnership with the Department of Fisheries and Oceans of Canada (Aquaculture Collaborative Research and Development Program, project 17-G-02 led by M.R.S.C.), a NSERC Discovery Grant to R.F. (RGPIN-2017-04294), and a Total Development Fund from the New Brunswick Department of Agriculture, Aquaculture and Fisheries to R.F.Peer reviewe

Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies

Objective: To characterize 414 patients with primary SS who developed haematological malignancies and to analyse how the main SS- and lymphoma-related features can modify the presentation patterns and outcomes. Methods: By January 2021, the Big Data Sjögren Project Consortium database included 11 966 patients fulfilling the 2002/2016 classification criteria. Haematological malignancies diagnosed according to the World Health Organization (WHO) classification were retrospectively identified. Results: There were 414 patients (355 women, mean age 57 years) with haematological malignancies (in 43, malignancy preceded at least one year the SS diagnosis). A total of 376 (91%) patients had mature B-cell malignancy, nearly half had extranodal marginal zone lymphoma (MZL) of mucosa-associated lymphoid tissue (MALT lymphoma) (n = 197), followed by diffuse large B-cell lymphoma (DLBCL) (n = 67), nodal MZL lymphoma (n = 29), chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) (n = 19) and follicular lymphoma (FL) (n = 17). Rates of complete response, relapses and death were 80%, 34% and 13%, respectively, with a 5-year survival rate of 86.5% after a mean follow-up of 8 years. There were significant differences in age at diagnosis (younger in MALT, older in CLL/SLL), predominant clinical presentation (glandular enlargement in MALT lymphoma, peripheral lymphadenopathy in nodal MZL and FL, constitutional symptoms in DLBCL, incidental diagnosis in CLL/SLL), therapeutic response (higher in MALT lymphoma, lower in DLBCL) and survival (better in MALT, nodal MZL and FL, worse in DLBCL). Conclusion: In the largest reported study of haematological malignancies complicating primary SS, we confirm the overwhelming predominance of B-cell lymphomas, especially MALT, with the salivary glands being the primary site of involvement. This highly-specific histopathological scenario is linked with the overall good prognosis with a 5-year survival rate of nearly 90%